Warning: Invalid argument supplied for foreach() in
/home/r3716923/public_html/kringle-pharma.com/wp-content/themes/kringle_pharma/view/single/default.php on line
21
2008.10.30
IND approval for ARF Phase Ia PDF
Kringle Pharma Achieved Permission to Conduct Phase 1 Clinical Studies on recombinant human HGF for the Treatment of ARF in US.
